Placental transfer of albendazole sulphoxide enantiomers in sheep

被引:12
作者
Capece, BPS
Pérez, R
Andaluz, A
Pérez, F
Garcia, F
Castells, G
Arboix, M
Cristòfol, C
机构
[1] Univ Autonoma Barcelona, Fac Vet, Dept Farmacol Terapeut & Toxicol, E-08193 Barcelona, Spain
[2] Univ Autonoma Barcelona, Fac Vet, Dept Med & Cirurgia Anim, E-08193 Barcelona, Spain
[3] Univ Concepcion, Fac Med Vet, Farmacol Lab, Chillan, Chile
关键词
albendazole sulphoxide; enantiomers; sheep; pregnancy; fetus;
D O I
10.1053/tvjl.2001.0628
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 [兽医学];
摘要
Albendazole sulphoxide (ABZSO) is an anthelmintic drug used in veterinary, practice. Its molecule has a chiral centre in the sulphur atom and racemic formulations are always used. The kinetics of the ABZSO enantiomers in the last third of pregnancy in ewes, and the placental transfer to the fetus, were studied after a single-dose oral administration (7.5 mg/kg) of a racemic formulation. In mothers, the area under the plasma concentration-time curve (AUC) and C-max values of (+)-ABZSO (42.4 +/- 10.5 mug/mL and 1.9 +/- 0.4 mug/mL, respectively) were higher than those of (-)-ABZSO (15.3 +/- 5.1 mug/mL and 1.0 +/- 0.3 mug/mL). The MRT values were 17.0 +/- 1.6 h for (+)-ABZSO and 13.1 +/- 1.8 h for (-)-ABZSO. Similar kinetic parameters were obtained in the fetus for both enantiomers, but the fetal concentrations were lower compared with values for the dam. The AUC ratio between (-)-ABZSO/(+)-ABZSO in the dam was 0.36 and in the fetuses 0.64, indicating a higher impairment for the (+)-enantiomer in its placental transfer to the fetus. (C) 2002 Published by Elsevier Science Ltd.
引用
收藏
页码:155 / 160
页数:6
相关论文
共 30 条
[1]
PHARMACOKINETICS OF ALBENDAZOLE, ALBENDAZOLE SULFOXIDE AND NETOBIMIN IN GOATS [J].
BENCHAOUI, HA ;
SCOTT, EW ;
MCKELLAR, OA .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1993, 16 (02) :237-240
[2]
BENOIT E, 1992, AM J VET RES, V53, P1663
[3]
BERROZPE JD, 1997, BIOFARMACIA FARMACOC, V1, P167
[4]
BOURGET P, 1994, THERAPIE, V49, P481
[5]
Pharmacokinetic behaviour of albendazole sulphoxide enantiomers in male and female sheep [J].
Capece, BPS ;
Castells, G ;
Pérez, F ;
Arboix, M ;
Cristòfol, C .
VETERINARY RESEARCH COMMUNICATIONS, 2000, 24 (05) :339-348
[6]
Comparative pharmacokinetics of netobimin metabolites in pregnant ewes [J].
Cristofol, C ;
Franquelo, C ;
Navarro, M ;
Carretero, A ;
Ruberte, J ;
Arboix, M .
RESEARCH IN VETERINARY SCIENCE, 1997, 62 (02) :117-120
[7]
TRANSPLACENTAL TRANSPORT OF NETOBIMIN METABOLITES IN EWES [J].
CRISTOFOL, C ;
CARRETERO, A ;
FERNANDEZ, M ;
NAVARRO, M ;
SAUTET, J ;
RUBERTE, J ;
ARBOIX, M .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1995, 20 (03) :167-171
[8]
Disposition of netobimin, albendazole, and its metabolites in the pregnant rat: Developmental toxicity [J].
Cristofol, C ;
Navarro, M ;
Franquelo, C ;
Valladares, JE ;
Carretero, A ;
Ruberte, J ;
Arboix, M .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 144 (01) :56-61
[9]
CRISTOFOL C, 1999, FUNDAM CLIN PHARM S1, V13, pS375
[10]
COMPARATIVE ENANTIOSELECTIVITY IN THE SULFOXIDATION OF ALBENDAZOLE IN MAN, DOGS AND RATS [J].
DELATOUR, P ;
BENOIT, E ;
BESSE, S ;
BOUKRAA, A .
XENOBIOTICA, 1991, 21 (02) :217-221